Wells Fargo & Company Oncternal Therapeutics, Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.28 - $0.64 $5 - $13	21 Added 0.33%	6,417 $3,000
Q3 2023 Nov 13, 2023	BUY	$0.29 - $0.48 $4 - $7	15 Added 0.24%	6,396 $1,000
Q2 2023 Aug 15, 2023	BUY	$0.28 - $0.79 $6 - $18	23 Added 0.36%	6,381 $2,000
Q1 2023 May 12, 2023	BUY	$0.63 - $1.3 $8 - $16	13 Added 0.2%	6,358 $5,000
Q4 2022 Feb 13, 2023	BUY	$0.86 - $22.2 $23 - $599	27 Added 0.43%	6,345 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.83 - $17.8 $14 - $302	17 Added 0.27%	6,318 $5,000
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.56 $51,721 - $115,265	-73,888 Reduced 92.14%	6,301 $7,000
Q1 2022 May 16, 2022	SELL	$1.37 - $2.43 $99,148 - $175,861	-72,371 Reduced 47.44%	80,189 $111,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $374,643 - $724,529	-165,041 Reduced 51.96%	152,560 $347,000
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $737,777 - $1.04 Million	218,925 Added 221.86%	317,601 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$4.75 - $9.39 $438,904 - $867,645	92,401 Added 1472.53%	98,676 $469,000
Q1 2021 May 13, 2021	BUY	$4.59 - $9.04 $5,163 - $10,169	1,125 Added 21.84%	6,275 $52,000
Q4 2020 Feb 09, 2021	BUY	$1.51 - $6.3 $7,676 - $32,029	5,084 Added 7703.03%	5,150 $26,000
Q3 2020 Nov 05, 2020	BUY	$1.7 - $3.28 $8 - $16	5 Added 8.2%	66 $0
Q1 2020 May 14, 2020	BUY	$2.49 - $4.39 $151 - $267	61 New	61 $0

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.